Offering Fact Sheet- GPEx® Lightning Technology
Abstract: Catalent’s GPEx® Lightning platform accelerates stable cell line development for complex biologics by combining high‑titer expression, tunable performance across modalities, and proven scalability from small‑scale to GMP production. With rapid cell pool generation in as little as 25 days and more than 60 generations of stability, GPEx® Lightning delivers a reliable, versatile, and integrated path from gene construct through to manufacturable cell lines—empowering teams to move next‑generation biologics forward faster.